Skip to main content
. 2017 Feb 12;4(2):ofx032. doi: 10.1093/ofid/ofx032

Figure 2.

Figure 2.

Relationship of human immunodeficiency virus (HIV) ribonucleic acid (RNA) measured in blood and cerebrospinal fluid (CSF) in patients with HIV and cryptococcal meningitis coinfection. (A) Human immunodeficiency virus RNA measured in plasma (in red) and in CSF (in blue) before antiretroviral therapy (ART) commencement. (B) Plasma/CSF ratio of HIV RNA and (C) correlation of plasma to CSF HIV RNA before ART commencement. (D) Human immunodeficiency virus RNA measured in plasma (in red) and in CSF (in blue) at time of neurological deterioration post-ART commencement. (E) Human immunodeficiency virus RNA measured in plasma (in red) and in CSF (in blue), and (F) plasma/CSF HIV RNA ratio (in black), before ART-commencement in those with future cryptococcosis-associated immune reconstitution inflammatory syndrome ([C-IRIS] large circles) and those with no neurological deterioration (ND) (small circles) during the 24-week follow-up period post-ART initiation. CI, confidence interval.